Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-31 @ 6:18 PM
Study NCT ID:
NCT01332305
Status:
COMPLETED
Last Update Posted:
2013-07-22
First Post:
2011-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
Sponsor:
XenoPort, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-07
First Submit QC Date:
None
Study First Post Date:
2011-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-28
Results First Submit QC Date:
None
Results First Post Date:
2011-05-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-15
Last Update Post Date:
2013-07-22
Last Update Post Date Type:
ESTIMATED